36th Annual Meeting and Exposition
of the Controlled Release Society

July 18-22, 2009
Bella Center
Copenhagen, Denmark

Bioactive Materials and Veterinary Mini-Symposia Speakers and Topics

AIDS – Back to Basics

Mario Clerici, Milano University, Italy, New Concepts in the Immunopathogenesis of HIV
Patrick Kiser, University of Utah, U.S.A., Delivery Systems Designed to Prevent HIV Transmission
Virendra Pandey, University of Medicine and Dentistry of New Jersey, U.S.A., Targeting Critical Regions of HIV-1 Genome for Intervention of HIV-1 Replication<
Patrick Sinko, Rutgers University, U.S.A., Active Targeting OF HIV Sanctuary Sites Using Biodegradable Peptide-Based PEG Nanocarriers

Hydrogels - From Nanoparticulate Drug Carriers to Tissue Engineering Scaffold

Innovations in Drug Delivery for Animal and Human Health Applications

Elias Fattal, University of Paris-XI, France, Delivery Systems for the Removal of Colonic Residual Antibiotic to Reduce the Emergence of Resistances
Mathieu Peyrou, Novartis Animal Health, Switzerland, Innovative PK Approaches in the Development of Controlled Release Veterinary Drugs
Michael Roberts, University of Queensland, Australia, Enhancement Strategies in Skin Penetration of Solutes and Nanoparticles: Species Differences
Thierry Vandamme, University of Strasbourg, France, Drug Delivery Systems Developed for Animal Health Applications

Malaria, 1 Million Deaths a Year and Still Counting!

Ann Grobler, North-West University, South Africa
Song Jian-Ping, Guangzhou University of Chinese Medicine, China
Solomon Nwaka, World Health Organization, Switzerland<
Richard Haynes, Hong Kong University, China, Artemisins-Marvellous Antimalrian Drugs-Advantages and Shortcomings

Neurodegeneration – Stopping the Clock

Christian Czech, F. Hoffmann-LaRoche, Switzerland, Disease Modification and New Biomarkers for Alzheimer’s Disease
Paul Gellert, AstraZeneca, U.K., Linking Disease and Delivery
John Hardy, National Institutes of Health, U.S.A., Fundamental Biology: New Therapeutic Opportunities
Samuel Svensson, AstraZeneca, Sweden

Translational Medicine–From the Lab to the Patient

Ruth Duncan, Cardiff University, U.K.
Jeff Evans, University of Glasgow Cancer Research, Scotland, Anti-Cancer Drug Development: Promises and Pitfalls
Tim Higenbottam, Chiesi Farmaceutici SpA, Italy
Alberto Gabizon, Shaare Zedek MC, Israel, Liposome Applications in Cancer Therapy-Doing New Tricks to Old Drugs
Jindrich (Henry) Kopecek, University of Utah, U.S.A., Polymeric Nanomedicines: Current Status and Future Prospects

All speakers, topics, and titles are subject to change.